BrightPath Biotherapeutics Co Ltd 4594.T-JP:Tokyo Stock Exchange

*Data is delayed | Exchange | JPY
Last | 10:16 AM JST
59.00UNCH (UNCH)
Volume
125,700
52 week range
56.00 - 149.00
Loading...
  • Open58.00
  • Day High60.00
  • Day Low58.00
  • Prev Close59.00
  • 52 Week High149.00
  • 52 Week High Date06/08/23
  • 52 Week Low56.00
  • 52 Week Low Date05/13/24

Key Stats

  • Market Cap25.81M
  • Shares Out70.74M
  • 10 Day Average Volume418,966.67
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-32.18

KEY STATS

  • Open58.00
  • Day High60.00
  • Day Low58.00
  • Prev Close59.00
  • 52 Week High149.00
  • 52 Week High Date06/08/23
  • 52 Week Low56.00
  • 52 Week Low Date05/13/24
  • Market Cap25.81M
  • Shares Out70.74M
  • 10 Day Average Volume418,966.67
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-32.18

RATIOS/PROFITABILITY

  • EPS (TTM)-13.10
  • P/E (TTM)-4.50
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On BrightPath Biotherapeutics Co Ltd

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
BrightPath Biotherapeutics Co., Ltd. is a Japan-based company mainly engaged in the development of pharmaceutical products. The Company is a biopharmaceutical venture company focused on developing cancer immunotherapeutic. The Companies business model covers drug discovery research and early clinical development of cancer immunotherapy; conducting of early-phase clinical trials; and development, manufacturing, and launching of the drugs as commercial products in Japan and...
Kenichi Nagai
President, Chief Executive Officer, Representative Director
Yoichi Takeshita
Chief Financial Officer, Director
Address
7F, Kojimachi Central Bldg
2-2-4, Koji-machi
Chiyoda-ku, TKY
102-0083
Japan